DNA Methylation Changes in Human Papillomavirus-Driven Head and Neck Cancers

• Published in: Cells (Basel, Switzerland) Vol. 9; no. 6; p. 1359
• Main Authors: Ekanayake Weeramange, Chameera, Tang, Kai Dun, Vasani, Sarju, Langton-Lockton, Julian, Kenny, Liz, Punyadeera, Chamindie
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI 31-05-2020; MDPI AG
• Subjects: Alphapapillomavirus - genetics; Alphapapillomavirus - physiology; Carcinogenesis - genetics; Carcinogenesis - pathology; DNA methylation; DNA Methylation - genetics; DNA, Viral - genetics; Genome, Viral; head and neck cancer; Head and Neck Neoplasms - diagnosis; Head and Neck Neoplasms - genetics; Head and Neck Neoplasms - therapy; Head and Neck Neoplasms - virology; human papillomavirus; Humans; Review; head and neck cancer; DNA methylation; human papillomavirus
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells9061359

Disruption of DNA methylation patterns is one of the hallmarks of cancer. Similar to other cancer types, human papillomavirus (HPV)-driven head and neck cancer (HNC) also reveals alterations in its methylation profile. The intrinsic ability of HPV oncoproteins E6 and E7 to interfere with DNA methyltransferase activity contributes to these methylation changes. There are many genes that have been reported to be differentially methylated in HPV-driven HNC. Some of these genes are involved in major cellular pathways, indicating that DNA methylation, at least in certain instances, may contribute to the development and progression of HPV-driven HNC. Furthermore, the HPV genome itself becomes a target of the cellular DNA methylation machinery. Some of these methylation changes appearing in the viral long control region (LCR) may contribute to uncontrolled oncoprotein expression, leading to carcinogenesis. Consistent with these observations, demethylation therapy appears to have significant effects on HPV-driven HNC. This review article comprehensively summarizes DNA methylation changes and their diagnostic and therapeutic indications in HPV-driven HNC.